Elke Langkopf
Boehringer Ingelheim (Germany)(DE)University of Applied Sciences Biberach(DE)Institute of Medicinal Plant Development(CN)
Publications by Year
Research Areas
Catalytic Alkyne Reactions, Cyclopropane Reaction Mechanisms, Catalytic C–H Functionalization Methods, Diabetes Treatment and Management, Asymmetric Synthesis and Catalysis
Most-Cited Works
- → Uses of Silicon-Containing Compounds in the Synthesis of Natural Products(1995)552 cited
- → 8-(3-(R)-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a Highly Potent, Selective, Long-Acting, and Orally Bioavailable DPP-4 Inhibitor for the Treatment of Type 2 Diabetes(2007)282 cited
- → (R)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a Novel Xanthine-Based Dipeptidyl Peptidase 4 Inhibitor, Has a Superior Potency and Longer Duration of Action Compared with Other Dipeptidyl Peptidase-4 Inhibitors(2008)278 cited
- → First Studies of the Transition Metal-Catalyzed [5+2] Cycloadditions of Alkenes and Vinylcyclopropanes: Scope and Stereochemistry(1998)184 cited
- → Transition Metal-Catalyzed [5 + 2] Cycloadditions of Allenes and Vinylcyclopropanes: First Studies of Endo−Exo Selectivity, Chemoselectivity, Relative Stereochemistry, and Chirality Transfer(1999)165 cited
- → β-Catenin and TGFβ signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition